ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: House Passes FY ’77 Money Bill, But Veto Seems Likely; NIH Relaxes Moonlighting Rule

August 20, 1976

“Over-Regulation” Threatens Health Care, Thompson Says.

June 15, 2001

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

Interview: “People don’t understand Clinical Trials.

September 5, 1997

S-1 After Surgery Improves Survival, Japanese Trial Finds

February 23, 2007

Brawley: CMS Got it Right in Lung Cancer Screening Decision

November 14, 2014